700. Identification and Whole-Genome Sequencing (WGS) of Meropenem-Vaborbactam (MV) Resistant Klebsiella pneumoniae (MVRKP) Among Patients Without Prior Exposure to MV: Collateral Damage

BACKGROUND: MV is a newly approved β-lactam/β-lactamase inhibitor combination (BLIC) for the treatment of complicated urinary tract infections (cUTI). Vaborbactam is a cyclic boronic acid BLI that was mainly developed as a potent inhibitor of KPC carbapenemases and other Ambler class A&C enzymes...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasmin, Mohamad, Chen, Liang, Marshall, Steven H, Kreiswirth, Barry N, Perez, Federico, Bonomo, Robert A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254692/
http://dx.doi.org/10.1093/ofid/ofy210.707

Ejemplares similares

Ejemplares similares